Overview

A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP1517 and Lanthanum Carbonate Hydrate

Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the effect of lanthanum carbonate hydrate on the pharmacokinetics (PK) of ASP1517 in non-elderly healthy male subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Astellas Pharma Inc
Collaborator:
FibroGen